Timothy Kelly

Timothy Kelly

Chief Tech/Sci/R&D Officer at CARIBOU BIOSCIENCES, INC.

Net worth: 128 700 $ as of 30/06/2026

57 year
Health Technology
Consumer Services
Producer Manufacturing

Profile

Timothy P.
Kelly
is currently Chief Technology Officer at Caribou Biosciences, Inc. since 2024.
Formerly, Mr. Kelly was Chairman & Chief Executive Officer at Oxford Biomedica Solutions LLC from 2022 to 2023; Chief Operating Officer at Homology Medicines, Inc. from 2021 to 2022; Head-Technical Operations at Sarepta Therapeutics, Inc. in 2017; Senior Vice President & Head-Biologics Operating at Shire Plc from 2016 to 2017; Head-Technical Operations at UCB SA from 2005 to 2009; Senior Director-International Operations at Biogen, Inc. from 1998 to 2005.
Education includes undergraduate studies at the United States Air Force Academy and an MBA from Troy University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/02/2026 73,125 ( 0.07% ) 128 700 $ 30/06/2026

Timothy Kelly active positions

CompaniesPositionStart
CARIBOU BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 07/01/2024

Former positions of Timothy Kelly

CompaniesPositionEnd
Chief Executive Officer 01/07/2023
Q32 BIO INC. Chief Operating Officer 10/03/2022
SAREPTA THERAPEUTICS, INC. Corporate Officer/Principal 01/05/2017
SHIRE Corporate Officer/Principal 01/01/2017
UCB Corporate Officer/Principal 01/01/2009
See the detail of Timothy Kelly's experience

Training of Timothy Kelly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Producer Manufacturing